{
    "2018-01-31": [
        [
            {
                "time": "2018-01-31",
                "original_text": "Vertex Beats Views, Closes In On Cystic Fibrosis Treatments",
                "features": {
                    "keywords": [
                        "Vertex",
                        "Beats",
                        "Cystic Fibrosis",
                        "Treatments"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Beat-And-Raise",
                        "Dives",
                        "Drug Stocks"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-31",
                "original_text": "Despite Tax-Cut, Pfizer Inc. Remains a Slow-Growth Company",
                "features": {
                    "keywords": [
                        "Tax-Cut",
                        "Pfizer",
                        "Slow-Growth"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Q4 Earnings",
                        "Raises",
                        "2018 EPS Guidance"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "AbbVie Is Ruining Pharma Earnings Season",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Ruining",
                        "Pharma",
                        "Earnings Season"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "The Zacks Analyst Blog Highlights: Bank of America, Citigroup, AbbVie, 3M, Starbucks and Halliburton",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Bank of America",
                        "Citigroup",
                        "AbbVie",
                        "3M",
                        "Starbucks",
                        "Halliburton"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "financials",
                        "healthcare",
                        "consumer goods",
                        "industrials"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View",
                "features": {
                    "keywords": [
                        "Anthem",
                        "Q4 Earnings",
                        "Revenues",
                        "'18 View"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "insurance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Johnson & Johnsonâ€™s Medical Devices Business in 4Q17",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Medical Devices",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "The Best Arthritis Drug/Treatment Stocks on the Market Right Now",
                "features": {
                    "keywords": [
                        "Arthritis",
                        "Drug/Treatment",
                        "Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-31",
                "original_text": "Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX",
                "features": {
                    "keywords": [
                        "Drug/Biotech Stocks",
                        "Q4 Earnings",
                        "LLY",
                        "VRTX"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}